First Page | Document Content | |
---|---|---|
Date: 2016-07-02 14:50:25Health Medicine Breakthrough therapy Specialty drugs Gilead Sciences Healthcare-associated infections Cyclopropanes Sofosbuvir Ledipasvir National Institute for Health and Care Excellence Hepatitis National Health Service | Microsoft Word - GILEAD BRIEFINGAdd to Reading ListSource URL: www.ukts.orgDownload Document from Source WebsiteFile Size: 102,77 KBShare Document on Facebook |
California Schools VEBA Important Benefit Update Attention Member IMPORTANT: If you have not received your Welcome Kit with your ID cards, pleaseDocID: 1rr76 - View Document | |
Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar NoDocID: 1rqYi - View Document | |
February 2016 Rx Price Watch ReportDocID: 1rosR - View Document | |
présenteit - mediA - phA rmADocID: 1riP0 - View Document | |
PDF DocumentDocID: 1ri6p - View Document |